The House Ways and Means Committee today held a hearing on the Department of Health and Human Services’ fiscal year 2019 budget request, at which HHS Secretary Alex Azar testified. The non-binding budget request proposes hundreds of billions of dollars in reductions to Medicare and Medicaid over 10 years, as well as a number of provisions related to drug pricing, opioids and other health-related issues. In his opening remarks, Chairman Kevin Brady (R-TX) said the committee has developed “consensus solutions” on health care and is “eager to work with the Trump administration to build on them wherever possible,” including “taking action to reduce the cost of prescription drugs.” Committee members also urged aggressive action to address the opioid crisis, and Democrats criticized the proposed cuts to Medicare and Medicaid. Ranking Member Richard Neal (D-MA) noted that the budget request “cuts more than $200 billion in payments to hospitals,” threatening additional hospital closures and the jobs they provide. Reps. Terri Sewell (D-AL) and Tom Rice (R-SC) also expressed concern about rural hospital closures. “We have consistently asked rural hospitals to do more with less,” Sewell said. “As a result, 83 rural hospitals have closed since 2010 across the country.”

Related News Articles

Headline
The Medicare Payment Advisory Commission Dec. 4 and 5 discussed draft payment update recommendations for 2027, which the commission will vote on in January.…
Headline
The Trump administration announced a trade agreement with the U.K. Dec. 1 on pharmaceuticals that exempts U.K. drug products from Section 232 tariffs. In…
Headline
The House Dec. 1 passed the Hospital Inpatient Services Modernization Act (H.R. 4313), legislation extending certain Medicare waivers authorizing the hospital-…
Headline
The Centers for Medicare & Medicaid Services announced Dec. 1 that it intends to expand the Inpatient Rehabilitation Facility Review Choice Demonstration…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 announced lower prices for 15 Medicare Part D drugs selected for the second cycle of negotiations…
Headline
The Centers for Medicare & Medicaid Services Nov. 25 issued a proposed rule for policies governing the Medicare Advantage and Part D programs for 2027. CMS…